182 related articles for article (PubMed ID: 18395925)
1. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
Visintin M; Melchionna T; Cannistraci I; Cattaneo A
J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
[TBL] [Abstract][Full Text] [Related]
2. The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation.
Visintin M; Quondam M; Cattaneo A
Methods; 2004 Oct; 34(2):200-14. PubMed ID: 15312673
[TBL] [Abstract][Full Text] [Related]
3. A protein silencing switch by ligand-induced proteasome-targeting intrabodies.
Melchionna T; Cattaneo A
J Mol Biol; 2007 Nov; 374(3):641-54. PubMed ID: 17950312
[TBL] [Abstract][Full Text] [Related]
4. Engineering novel binding proteins from nonimmunoglobulin domains.
Binz HK; Amstutz P; Plückthun A
Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
[TBL] [Abstract][Full Text] [Related]
5. Engineered affinity proteins--generation and applications.
Grönwall C; Ståhl S
J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
[TBL] [Abstract][Full Text] [Related]
6. The rapid discovery of engineered antibodies.
Wang M; He M
IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
[TBL] [Abstract][Full Text] [Related]
7. Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology.
Axelsson F; Persson J; Moreau E; Côté MH; Lamarre A; Ohlin M
N Biotechnol; 2009 Sep; 25(6):429-36. PubMed ID: 19464399
[TBL] [Abstract][Full Text] [Related]
8. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
9. Selection of peptides interfering with protein-protein interaction.
Gaida A; Hagemann UB; Mattay D; Räuber C; Müller KM; Arndt KM
Methods Mol Biol; 2009; 535():263-91. PubMed ID: 19377990
[TBL] [Abstract][Full Text] [Related]
10. Protein interaction mapping for target validation: the need for an integrated combinatory process involving complementary approaches.
Strosberg AD
Curr Opin Mol Ther; 2002 Dec; 4(6):594-600. PubMed ID: 12596362
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interference with protein-protein interactions mediated by coiled-coil motifs.
Strauss HM; Keller S
Handb Exp Pharmacol; 2008; (186):461-82. PubMed ID: 18491064
[TBL] [Abstract][Full Text] [Related]
12. Engineering antibodies by yeast display.
Boder ET; Raeeszadeh-Sarmazdeh M; Price JV
Arch Biochem Biophys; 2012 Oct; 526(2):99-106. PubMed ID: 22450168
[TBL] [Abstract][Full Text] [Related]
13. A computationally guided protein-interaction screen uncovers coiled-coil interactions involved in vesicular trafficking.
Zhang H; Chen J; Wang Y; Peng L; Dong X; Lu Y; Keating AE; Jiang T
J Mol Biol; 2009 Sep; 392(1):228-41. PubMed ID: 19591838
[TBL] [Abstract][Full Text] [Related]
14. A new generation of protein display scaffolds for molecular recognition.
Hosse RJ; Rothe A; Power BE
Protein Sci; 2006 Jan; 15(1):14-27. PubMed ID: 16373474
[TBL] [Abstract][Full Text] [Related]
15. Method for generation of human hyperdiversified antibody fragment library.
Mondon P; Souyris N; Douchy L; Crozet F; Bouayadi K; Kharrat H
Biotechnol J; 2007 Jan; 2(1):76-82. PubMed ID: 17225253
[TBL] [Abstract][Full Text] [Related]
16. Protein interactions: analysis using allele libraries.
Chappell TG; Gray PN
Adv Biochem Eng Biotechnol; 2008; 110():47-66. PubMed ID: 18528666
[TBL] [Abstract][Full Text] [Related]
17. Intracellular antibodies (intrabodies) and their therapeutic potential.
Lo AS; Zhu Q; Marasco WA
Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
[TBL] [Abstract][Full Text] [Related]
18. A function for AAMP in Nod2-mediated NF-kappaB activation.
Bielig H; Zurek B; Kutsch A; Menning M; Philpott DJ; Sansonetti PJ; Kufer TA
Mol Immunol; 2009 Aug; 46(13):2647-54. PubMed ID: 19535145
[TBL] [Abstract][Full Text] [Related]
19. Intrabody applications in neurological disorders: progress and future prospects.
Miller TW; Messer A
Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
[TBL] [Abstract][Full Text] [Related]
20. GFP-p65 knock-in mice as a tool to study NF-kappaB dynamics in vivo.
De Lorenzi R; Gareus R; Fengler S; Pasparakis M
Genesis; 2009 May; 47(5):323-9. PubMed ID: 19263497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
